MONCYTE Health

MONCYTE Health's technology provides insight into immune cells that contribute to inflammation in atherosclerotic plaques, helping to better understand differences in cardiovascular risk. They can combine, for the first time, treatment recommendation with risk assessment by quantifying differences in lipid uptake and storage in white blood cells, including monocytes. This will enable prioritization of more effective combination therapies for those persons who need them.